AIM
ARNA

Acrospire Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Acrospire Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-629
Closed -$11K – 1680
2017
Q2 		$11K Sell
629
-3,349
-84% -$45.9K 0.01% 1781
2017
Q1 		$58K Buy
3,978
+168
+4% +$2.49K 0.05% 809
2016
Q4 		$54K Buy
3,810
+3,680
+2,831% +$57K 0.02% 1356
2016
Q3 		$2K Sell
130
-410
-76% -$6.8K ﹤0.01% 1920
2016
Q2 		$9K Buy
+540
New +$9.65K 0.01% 1777

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acrospire Investment Management's ARNA Position: Q3 2017 in Review

Acrospire Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2017, closing a stake of 629 shares — an estimated $11K sold.

Acrospire Investment Management first reported a position in ARNA in Q2 2016 and held it in 5 quarters. The position peaked at $58K in Q1 2017. 119 funds tracked by Wall St. Rank hold ARNA as of Q3 2017.

  • Acrospire Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 629 Arena Pharmaceuticals Inc shares in Q3 2017, an estimated $11K.
  • Acrospire Investment Management first reported a position in Arena Pharmaceuticals Inc in Q2 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Arena Pharmaceuticals Inc position peaked at $58K in Q1 2017.
  • 119 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.